Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
MPS Limited today announced that its Artificial Intelligence Management System (AIMS) has been certified to ISO/IEC 42001:2023, the world's first international standard for AI management systems. The certification was awarded by DNV Business Assurance, which is accredited by the Dutch Accreditation Council (RvA), following a comprehensive multi-stage audit, and confirms that MPS develops, deploys, and manages AI under a governed framework covering risk assessment, human oversight, data governanc
MPS Ltd (BOM:532440) achieves its strongest first quarter ever, driven by significant revenue and profit growth, while navigating client rationalization and management changes.
MPS Ltd reports its most profitable year with significant revenue growth and outlines ambitious targets for FY27 and beyond.
MPS Limited, a leading global provider of content, platforms and learning solutions, today announced the appointment of Ms. Deepti Singh as Chief People Officer (CPO), effective March 23, 2026.
Unbound Medicine, Inc. and MPS Limited today announced that MPS, through its wholly owned subsidiary MPS North America LLC, has acquired Unbound Medicine. The acquisition combines Unbound's AI-powered clinical decision-support and healthcare education platform with MPS' global technology infrastructure, platform engineering capabilities, and learning solutions network.
MPS Ltd (BOM:532440) reports robust performance in Q3 FY26 with significant growth in Education Solutions and a strategic acquisition to enhance its market presence.
MPS Ltd (BOM:532440) reports robust revenue and profit growth, driven by AI efficiencies and strategic focus on high-growth verticals.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.